Skip navigation
Home
Menu
Menu
Study
Student life
Research and innovation
Global
About us
Staff
Students
Search the site
Centre of Excellence for Long-acting Therapeutics
Menu
About us
LONGEVITY
HALo
Nanotherapeutics Hub
Teoreler
PKRxiv
LAPaL
Blog
Our News
Events
Contact us
News
Engineers develop a better way to deliver long-lasting drugs
28 March 2025
Long-acting treatment benefits postpartum women with HIV and their babies
21 March 2025
TaiMed Biologics to Present Late-Breaking Phase IIa Data at CROI 2025 on Long-Acting TMB-365/TMB-380 Regimen for HIV Maintenance Therapy.
21 March 2025
ViiV announced three different long-acting HIV treatment and PREP news pieces this week
14 March 2025
Gilead present two sets of new data for HIV prevention and treatment at CROI 2025
14 March 2025
Depemokimab applications accepted for review by the US FDA for asthma with type 2 inflammation and for chronic rhinosinusitis with nasal polyps (CRSwNP)
07 March 2025
ANEA and TAG Stand in Solidarity with Demonstrators Fighting to Save PEPFAR
28 February 2025
Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor ABI-1179 in Development for
28 February 2025
Daré Bioscience and Theramex Announce Co-Development and Licensing Agreement for a Potential Biodegradable Long-Acting Contraceptive Implant
28 February 2025
FDA Acceptance of Supplemental New Drug Application for UZEDY(R) Extended-Release Injectable Suspension as a Treatment of Bipolar I Disorder
28 February 2025
News
Engineers develop a better way to deliver long-lasting drugs
28 March 2025
Long-acting treatment benefits postpartum women with HIV and their babies
21 March 2025
TaiMed Biologics to Present Late-Breaking Phase IIa Data at CROI 2025 on Long-Acting TMB-365/TMB-380 Regimen for HIV Maintenance Therapy.
21 March 2025
ViiV announced three different long-acting HIV treatment and PREP news pieces this week
14 March 2025
Gilead present two sets of new data for HIV prevention and treatment at CROI 2025
14 March 2025
Depemokimab applications accepted for review by the US FDA for asthma with type 2 inflammation and for chronic rhinosinusitis with nasal polyps (CRSwNP)
07 March 2025
ANEA and TAG Stand in Solidarity with Demonstrators Fighting to Save PEPFAR
28 February 2025
Older Stories
.jpg)
